PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals: Ownership & structure

AstraZeneca holds 10.44% of PhaseBio Pharmaceuticals.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

AstraZeneca holds 10.44% of PhaseBio Pharmaceuticals.

Holders
owner of (stated on the holder) · wikidata.org ↗
10.44%
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
NEAVia a fund
672 portfolio companies